Information For Authors
- Manuscript Submission Guidelines
- Author Benefits Program
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
Mary Ann Liebert, Inc. Submission Benefits Package
Your submission to Photobiomodulation, Photomedicine, and Laser Surgery provides you with robust tools and support to ensure maximum impact and readership for your work. By submitting your manuscript, you’ll receive:
- Rapid, rigorous peer-review and editorial attention
- Immediate deposit to PubMed and other indexing services upon online publication
- Exposure to thousands of thought-leaders in your field, maximizing readers, citations, and downloads
- Fast Track article publication
- Global availability in over 170 countries
- Open Access publication options
INSTRUCTIONS FOR AUTHORS
Photobiomodulation, Photomedicine, and Laser Surgery provides rapid publication of new and cutting-edge techniques and research in phototherapy, low level laser therapy (LLLT), and laser medicine and surgery.
Book reviews are published as space permits.
Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, except in the form of an abstract. Prior abstract publications should be described in the form of a footnote to the title. Published manuscripts become the sole property of the Journal and will be copyrighted by Mary Ann Liebert, Inc. By submitting a manuscript to the Journal, the author(s) agree(s) to each of these conditions. In addition, the author(s) explicitly assign(s) any copyrighted ownership he/she (they) may have in such manuscript to the Journal.
USE OF ENGLISH LANGUAGE
All submissions must be in English. Appropriate use of the English language is a requirement for review and publication in Photobiomodulation, Photomedicine, and Laser Surgery. For authors whose native language is not English, we suggest using a service that can aid in the translation and rewriting of material into correct and proper English usage. The Publisher offers this service with a subsidy from the author prior to official submission. It is important to note that employing the use of the Publisher’s service does not guarantee acceptance of any paper. All submissions are subject to peer review.
Page charges for this journal are set at $65.00 USD per typeset page. Nonpayment of page charges may result in a delay in publication.
There is a small fee for publishing figures in color, to be subsidized by the author(s). Contact AuthorBenefitsProgram@liebertpub.com for details.
PREPARATION OF MANUSCRIPT
All submitting authors are required to complete their submissions using an ORCID identifier. Please visit the ORCID website for more information, or to register.
Manuscripts must be submitted online at the following URL:
CREATE AN ACCOUNT IN MANUSCRIPT CENTRAL
If you do not already have an account in Manuscript Central for Photobiomodulation, Photomedicine, and Laser Surgery, you will need to create one. Once you create your account, you may log in to the system to begin your submission.
NOTE: Plagiarism Detection
All accepted manuscripts will be processed through plagiarism detection software, and any notice of acceptance is considered conditional, pending the review and verification of the plagiarism detection report. If the report detects a high incidence of overlap in text, the Editor-in-Chief reserves the right to rescind the decision to accept the paper.
Text recycling may be discovered in a submitted manuscript by editors and/or reviewers, or by the use of plagiarism-detection software. If any discovered overlap is considered minor, action may not be necessary, or the authors may be asked to rewrite the overlapping sections and cite their previous article(s) if they have not already done so.
More significant overlap may result in immediate rejection, or rescinding of a decision to accept.
Please follow the requested style to avoid any delays in publication. Consult a current issue of the journal for the exact format.
We endorse the “Uniform Requirements of Manuscripts Submitted to Biomedical Journals.”
Prepare manuscripts double spaced throughout. Please submit text of manuscripts in Microsoft Word. The title page should include the title of the manuscript, all authors’ names and complete affiliations, the source of a work or study (if any), and a running title of about 45 characters. The corresponding author should also be designated on the title page. The second page should consist of a structured abstract of no more than 250 words which should be self-explanatory without reference to the text. The structured format for the abstract consists of 1) the objective of one or two sentences; 2) the background data is a short paragraph describing the present status of the field; 3) methods is a statement of the plan and/or methods used in the study; 4) the results is a concise summary of the essential features verified by the data; and 5) the conclusions is a brief description of the objective findings of the study. References are not permitted in the abstract.
Manuscripts should follow this format: abstract, introduction, materials and methods, results, discussion, conclusion and summary, acknowledgments, author disclosure(s), and a complete list of cited references, prepared in the proper journal style (see http://endnote.com/downloads/style/photomedicine-and-laser-surgery). Number pages consecutively. At the end of the paper, give the name and address of the individual to whom reprint requests should be directed. Authors are encouraged to suggest the names of appropriate reviewers.
GUIDELINES ON LENGTH
Manuscript length varies according to the type of paper, subject matter and authors' judgment. Original research papers are generally less than 3000 words; review papers may be longer (up to 6000 words and should have a 150-word abstract); only rare, novel, or exceptional Case Reports of up to 1500 words will be considered; Short Reports should be less than 1000 words with no more than one table or illustration and up to 10 references. We are happy to entertain unsolicited editorials of up to 1000 words, which will be externally peer reviewed. Letters to the Editor should be no longer than 500 words with no more than 5 references except in exceptional circumstances when the argument for this should be laid out in an accompanying letter. One table or illustration may accompany letters. Personal view papers, drug/therapy/intervention reports, critical review and debate and reports drawing attention to potential clinical problems are welcomed.
All submitted manuscripts must include a detailed description of the treatment (light or energy delivery) as well as the device used in performing such treatment (light or energy delivery). A description of the device must include the name of the manufacturer, the manufacturer’s geographical location, the equipment model, power output, the wavelength of the light source, including a description of the source, e.g., solid state, gas, laser diode, light-emitting diode, etc., and the shape, size and type of treatment applicator (delivery system or device) used in delivering treatment. Similarly, a detailed description of treatment parameters is necessary; and should at minimum include:
- The irradiance or power density measured in W/cm2,
- The dose in the form of energy density or fluence measured in J/cm2,
- The duration of each treatment session, preferably measured in seconds,
- The frequency of treatment (i.e., the number of times treatment was done
per week), and
- The cumulative dose given, i.e., the individual doses multiplied by the number of treatment sessions.
It is highly recommended that the parameters used be provided in the form of a table in addition to their inclusion in the text of the Materials and Methods section of the manuscript.
Please refer to the following references for additional information and guidance in the reporting of parameters prior to submission of manuscripts:
1. Enwemeka CS. Standard parameters in laser phototherapy. Photomed Laser Surg
2. Enwemeka CS. Intricacies of dose in laser phototherapy for tissue repair and pain
relief. Photomed Laser Surg 2009;27:387-393.
3. Huang YY, Chen ACH, Carroll JD, Hamblin MR. Biphasic dose response in low level light
therapy. Dose Response 2009;7:358-383.
4. Jenkins PA, Carroll JD. How to report low-level laser therapy (LLLT)/ Photomedicine
dose and beam parameters in clinical and laboratory studies. Photomed Laser Surg
5. WALT. Standards for the design and conduct of systematic reviews with low-level laser
therapy for musculoskeletal pain and disorders. Photomed Laser Surg
6. WALT recommended treatment doses for low level laser therapy:
Tables should be submitted in Microsoft Word and provided in one separate file from the main text of the manuscript. Tables should be cited in the text in order and identified as Table 1, Table 2, etc. Along with the table number, each table should have a title.
Please follow these instructions for submitting illustrations:
• Do not embed figures in the Microsoft Word text files.
• Do not prepare any figures in Microsoft Word.
• Prepare figures in either .tiff or .eps format.
• Line illustrations must be submitted at 900 DPI.
• Black and white halftones and color art must be submitted at 300 DPI.
• PowerPoint and Excel files cannot be uploaded.
• Color art must be saved as CMYK—not RGB.
• Please name your artwork files with the submitting author’s name, followed by the
figure number (e.g., SmithFig1).
Legends for illustrations with numbers corresponding to the figures should be uploaded as a separate file.
Abbreviations of journal titles should follow the style of Medline or the Council of Biology Editors Style Manual (Arlington, VA, American Institute of Biological Sciences). The first time an uncommon abbreviation appears, it should be preceded by the full name for which it stands.
Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org for further guidance. If no conflicts exist, the authors must state “No competing financial interests exist."
The reference section must be typed double spaced and references cited within text should be numbered consecutively as they appear. Those appearing for the first time in tables and figures must be numbered in sequence with those cited in the text where the table or figure is mentioned. All numbered in-text citations should be superscript with no parentheses. List all the authors when there are six or fewer. When there are seven or more, list the first three, then “et al.” Sample references are:
1. Lahita R, Liuger J, Drayer DE, Koffler D, Reidenberg MM. Antibodies to nuclear antigens in patients treated with procainamide. J Cardiovasc Ultrason 1982;1:12-20.
2. Bearns AG. Wilson’s disease. In: The Metabolic Basis of Inherited Disease. JB Stanbury, JB Wynnegaarden, DS Frederickson (eds.). New York: McGraw-Hill, 1972; pp. 1033–1050.
References to government publications should include the department, bureau or office, title, location of publisher, publisher, year, pages cited, and most important, the publication series, report, or monograph number.
Numbered references to personal communications, unpublished data and manuscripts either “in preparation” or “submitted for publications” are unacceptable. If essential, such material may be incorporated in the appropriate place in the text.
Please upload individual files of all manuscript material — do NOT upload a single PDF file containing all text, figure, and table files of your paper. Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.
Upon acceptance of any manuscript processed through Manuscript Central, all authors will receive a follow-up email with instructions on completing our online Copyright Agreement form. Each author will receive individualized links to their copyright form. Authors will not be permitted to “share” or forward these individualized links as they are unique to each author. Therefore, it is critical to ensure the accuracy of ALL authors’ email addresses when uploading submissions to ensure the proper delivery of each copyright form, and any other pertinent email communications.
To complete the pending copyright form, please log on to the system using the author’s credentials. Enter your Author Center and complete the forms located under “Manuscripts I Have Coauthored,” or “Manuscripts with Decisions” if you are listed as the corresponding author on the paper.
The corresponding author is responsible for communicating with coauthors to ensure they have completed the online copyright form. Authors not permitted to release copyright must still return the form acknowledging the statement of the reason for not releasing the copyright.
Failure by all authors to submit this form will result in a delay in publication.
It is the Journal’s policy that a manuscript has only ONE corresponding author listed on a paper. This designation should be determined at the time of submission. Additions to corresponding authors are not permitted after acceptance or in page proofs.
PATIENT RELEASE INFORMATION
If applicable, it is incumbent upon the author(s) to obtain patient release statements of permission to reproduce any identifiable images of patients. The submitting author should provide written confirmation of this critical information. Acceptable forms of consent statements are emails or letters. The Journal does not provide a generic patient release form.
The written consent must contain specific information about the patient's name, age, and if pertinent, conservatorship -- as well as stated permission -- granting the Journal the rights to publish the photograph within its pages (which includes the name of the Journal and article title).
Materials taken from other sources must be accompanied by a written statement from both author and publisher giving permission for reproduction. If clearances are required by the author’s institution, statements concerning such clearance should be provided in the manuscript. Obtain and submit written permission from authors to cite unpublished data or papers still in press.
Page proofs will be sent to the (one) corresponding author as designated when the manuscript was uploaded to Manuscript Central. It is the corresponding author’s responsibility to share the page proofs with co-authors and to coordinate all authors’ corrections into one proof. The Publisher will not accept corrections from multiple authors.
Changes in authorship in page proofs are NOT permitted under any circumstance.
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
Photobiomodulation, Photomedicine and Laser Surgery is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215, Telephone: (914) 740–2100; fax: (914) 740–2108; Website: www.liebertpub.com/pho
Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option
Does your research funder have an open access mandate or would you like to expand the dissemination of your research?
The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.
The benefits of Liebert Open Access include:
- High visibility; open access articles are freely available online upon publication
- You retain copyright with the open access license allowing broad dissemination of your research
- You can freely share your article in repositories and research networks without restrictions
- Easy compliance with open access mandates
- Rigorous editorial and peer-review
- Targeted email announcement featuring a direct link to article
Identification and Marketing
Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.
Copyright and Licensing
If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
Ordering Open Access
Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email firstname.lastname@example.org.
Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form. You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.
Publishing biomedical or biotechnology research?
Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.
*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.
Browse journals in the Liebert Open Access portfolio:
NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.
Publishing in Subscription Journals
By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.
Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.
The final published article (version of record) can never be archived in a repository, preprint server, or research network.
Publishing Open Access
Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email email@example.com or visit Liebert Open Access for more information.